Congress Presses FDA On Zohydro Approval As Product Launch Nears
This article was originally published in The Pink Sheet Daily
Executive Summary
Three Republican senators seek assurances about safeguards against, and monitoring for, abuse of Zogenix’s extended-release hydrocodone product, which is expected to reach commercial channels in early March.